What is the significance of a hematocrit of 47% with a normal hemoglobin level?

A hematocrit of 47% with normal hemoglobin is generally within normal range for adult males and requires no intervention unless accompanied by specific clinical features or symptoms.

Clinical Interpretation

This hematocrit value falls within the normal reference range for adult males (42-54%) and is below any threshold requiring intervention. 1 The key consideration is whether this represents true polycythemia or a normal variant, and whether any underlying pathology exists.

When to Investigate Further

The diagnostic possibility of polycythemia vera (PV) should only be entertained if 2:

• Hemoglobin/hematocrit is above the 95th percentile adjusted for sex and race
• Documented increase above baseline for the individual patient, regardless of where the value falls within reference range
• PV-related features present with borderline-high hematocrit:
  • Thrombocytosis
  • Leukocytosis
  • Microcytosis from iron deficiency
  • Splenomegaly
  • Aquagenic pruritus
  • Unusual thrombosis (including Budd-Chiari syndrome)
  • Erythromelalgia

In the absence of these features, a hematocrit of 47% requires no further workup. 2

Specific Thresholds for Action

For Congenital Heart Disease (CHD) Patients

Phlebotomy is NOT indicated for patients with CHD when hematocrit is <65% and hemoglobin <20 mg/dL without hyperviscosity symptoms (Class III recommendation). 1

Phlebotomy becomes reasonable only when:

• Hematocrit >65% with hyperviscosity symptoms (headache, lethargy) in absence of dehydration and iron deficiency
• Hematocrit >65% before noncardiac surgery

For Polycythemia Vera Management

If PV is diagnosed, target hematocrit is <45% for all patients to reduce thrombotic risk. 3 This applies to both men and women, though individualization to 42% may be appropriate for women or those with progressive vascular symptoms.

Common Pitfalls to Avoid

1. Do not assume hematocrit = 3 × hemoglobin: This relationship varies with age, disease states, and RBC characteristics. 4, 5 The ratio can range from 2.8-4.1 depending on clinical context.

2. Do not order red cell mass (RCM) measurement for hematocrit <60% without PV-related features—it is unlikely to be PV and can be addressed with more practical tests like serum EPO level. 2

3. Do not investigate for PV based solely on a hematocrit of 47% without other clinical indicators—this represents unnecessary testing and cost.

4. Recognize masked PV: Rare cases of JAK2-positive PV can present with normal hemoglobin/hematocrit, particularly with unusual site thrombosis. 6 Consider JAK2 testing if unexplained thrombosis occurs even with normal blood counts.

Recommended Approach

For a hematocrit of 47% with normal hemoglobin:

1. Verify the hemoglobin is truly normal for the patient's sex and age
2. Review for PV-related features (thrombocytosis, leukocytosis, splenomegaly, unusual thrombosis)
3. If no concerning features: Reassure and recheck in 3 months if clinically indicated 2
4. If PV-related features present: Proceed with serum EPO level, then bone marrow examination if indicated 2